A clinical research consortium sponsored by NIAID and JDRF
Clinical Trials: The Immune Tolerance Network accepts applications for novel clinical trials from all interested scientists from academia, industry and government, in the areas of:
Assays & Biomarkers: In addition, the ITN accepts applications for the development of novel tolerance assay or mechanistic studies, for the purposes of establishing new surrogate markers of immune tolerance and investigating the mechanisms of clinical tolerance. For example, the ITN will consider proposals that seek to better understand clinical tolerance by utilizing ITN tolerance assay resources in existing or planned clinical trials that are funded through other sources.
The ITN does NOT accept proposals for non-human or preclinical studies.
The ITN application process is a two-stage process designed to fast-track applications from proposal to protocol development. Applicants submit a short ~5-page Concept Proposal to the ITN containing a basic outline and justification of the proposed research. Applicants whose proposals are of interest to the ITN will then be asked to submit a more complete Full Application for review.
There is no deadline for submission of Concept Proposals - they are accepted throughout the year, with reviews taking place several times per year.
Applications should note that the ITN review process differs significantly from traditional study section reviews by maintaining a much more interactive flavor designed to assist potential investigators in the preparation of highly focused, relevant scientific proposals. The number of projects funded and the total available funding varies from year to year.
Complete guidelines and supplementary information is available for download below.
